申请人:Xue Chu-Biao
公开号:US20140155377A1
公开(公告)日:2014-06-05
The present invention relates to 3-cycloalkylaminopyrrolidine derivatives of the formula I:
(wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, Y and Z are as defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of chemokine receptors and more specifically as modulators of the CCR2 and/or CCR5 receptor. The compounds and compositions of the invention may bind to chemokine receptors, e.g., the CCR2 and/or CCR5 chemokine receptors, and are useful for treating diseases associated with chemokine, e.g., CCR2 and/or CCR5, activity, such as atherosclerosis, restenosis, lupus, organ transplant rejection and rheumatoid arthritis.
本发明涉及式I的3-环烷基氨基吡咯烷衍生物(其中R1,R2,R3,R4,R5,R6,R7,Y和Z如本文所定义),其作为趋化因子受体活性调节剂。特别地,这些化合物可作为趋化因子受体的调节剂,更具体地作为CCR2和/或CCR5受体的调节剂。本发明的化合物和组合物可以与趋化因子受体结合,例如CCR2和/或CCR5趋化因子受体,并可用于治疗与趋化因子,例如CCR2和/或CCR5活性相关的疾病,例如动脉粥样硬化、再狭窄、狼疮、器官移植排斥反应和类风湿性关节炎。